GC Biopharma Corp.

₩140,100As of Sun 8 Nov 2026, 12:00 UTC
KRX:006280Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 0.90%
Div yield 1.07%
ROE (4.54%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.58
PE TTM —
TSR TTM 9.10%
Mkt cap ₩1.599T
ROIC 2.15%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩133,138
(4.97%)
(98.34%)
Hold 9|6|5|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
3,000
3,068
3,374
3,628
29.23%
26.30%
26.65%
28.46%
Revenue₩B
115.1
117.1
115.9
115.2
5.26%
10.22%
4.71%
2.73%
Peers (US$1.179B)
Cap (US$)
PE
612.0M
10.54x
1.175B
23.26x
Capital
TTM
5Y
10Y
Leveragex
1.253
(0.054)
(0.073)
EBIT/Intx
3.378
0.150
0.156
Own earn%
(10.97)
14.63
29.06
Sh yield%
38.62
63.40
59.57
Owners
Insiders/Inst%
10.40
75.50
Short interest%
0.75
SBC / revenue%
5.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
3–7
$1 testx
—
Incr. ROIC%
−1